Potential contribution of lifestyle and socioeconomic factors to healthy user bias in antihypertensives and lipidlowering drugs

dc.contributor.authorMitsuyo Kinjo
dc.contributor.authorEdward Chia-Cheng Lai
dc.contributor.authorMaarit Jaana Korhonen
dc.contributor.authorRita L McGill
dc.contributor.authorSoko Setoguchi
dc.contributor.organizationfi=kliininen kemia|en=Clinical Chemistry|
dc.contributor.organization-code1.2.246.10.2458963.20.93148683050
dc.converis.publication-id29818588
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/29818588
dc.date.accessioned2022-10-28T14:41:29Z
dc.date.available2022-10-28T14:41:29Z
dc.description.abstract<p>Objectives Healthy user bias arises when users of preventive medications such as lipid-lowering drugs (LLDs), hormone replacement therapy and antihypertensive (AH) medications are healthier than non-users due to factors other than medication effects, making the medications appear more beneficial in observational studies of effectiveness and safety. The purpose of the study is to examine factors contributing to healthy user effect in patients taking AHs or LLDs.</p><p>Methods: Among patients with hypertension or hyperlipidaemia in a population-based sample from the National Health and Nutrition Examination Survey (1999–2010), we assessed the association between socioeconomic and lifestyle factors and the use of AHs/LLDs by logistic regression with adjustment for demographics and comorbidities in a cross-sectional study.</p><p>Results: When 9715 AH/LLD users were compared with 3725 non-users, AH/LLD users were more likely to be: highly educated (OR 1.2, 95% CI 1.2 to 1.3), non-impoverished (OR 1.3, 95% CI 1.2 to 1.4), current non-smokers (OR 1.2, 95% CI 1.1 to 1.4), physically active (OR 1.1, 95% CI 1.0 to 1.2) and consume more calcium (OR 1.1, 95% CI 1.0 to 1.3) but less likely to have normal body mass index (OR 0.6, 95% CI 0.6 to 0.7) or to meet dietary sodium recommendations (OR 0.8, 95% CI 0.7 to 0.9).</p><p>Conclusions: We identified several salutary lifestyle factors associated with AH/LLD use in a representative US population. Healthy user effect may be partly explained by better socioeconomic profiles and lifestyles in AH/LLD users compared with non-users.<br /></p>
dc.identifier.eissn2053-3624
dc.identifier.jour-issn2398-595X
dc.identifier.olddbid189705
dc.identifier.oldhandle10024/172799
dc.identifier.urihttps://www.utupub.fi/handle/11111/44792
dc.identifier.urlhttp://openheart.bmj.com/content/4/1/e000417
dc.identifier.urnURN:NBN:fi-fe2021042718800
dc.language.isoen
dc.okm.affiliatedauthorKorhonen, Maarit
dc.okm.discipline3142 Public health care science, environmental and occupational healthen_GB
dc.okm.discipline317 Pharmacyen_GB
dc.okm.discipline3142 Kansanterveystiede, ympäristö ja työterveysfi_FI
dc.okm.discipline317 Farmasiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherBMJ Publishing Group
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1136/openhrt-2016-000417
dc.relation.ispartofjournalOpen Heart
dc.relation.issue1
dc.relation.volume4
dc.source.identifierhttps://www.utupub.fi/handle/10024/172799
dc.titlePotential contribution of lifestyle and socioeconomic factors to healthy user bias in antihypertensives and lipidlowering drugs
dc.year.issued2017

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
e000417.full.pdf
Size:
390.32 KB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF